Geneos Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22K | Sell |
439
-439
| -50% | -$2.22K | ﹤0.01% | 2788 |
|
|
2025
Q1 | $4.64K | Buy |
878
+328
| +60% | +$1.74K | ﹤0.01% | 2767 |
|
|
2024
Q4 | $3.72K | Buy |
550
+200
| +57% | +$1.35K | ﹤0.01% | 2436 |
|
|
2024
Q3 | $2.31K | Hold |
350
| – | – | ﹤0.01% | 2265 |
|
|
2024
Q2 | $2.63K | Hold |
350
| – | – | ﹤0.01% | 1839 |
|
|
2024
Q1 | $3.49K | Buy |
+350
| New | +$3.49K | ﹤0.01% | 1785 |
|